(Q5207712)

English

daclatasvir

chemical compound

BMS-790052
BMS 790052
BMS790052
Dimethyl N,N'-(biphenyl-4,4'-diylbis{1H-imidazole-5,2-diyl-((2S)-pyrrolidine-2,1- diyl)((1S)-1-(1-methylethyl)-2-oxoethane-2,1-diyl)})dicarbamate
Daclatasvir
EBP 883
N,N'-[[1,1'-Biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]biscarbamic acid C,C'-dimethyl ester
Daklinza

In more languages

default for all languages

No label defined

No description defined

Statements

type of chemical entity

0 references

heterocyclic compound

0 references

1 reference

Daclatasvir (English)

language of work or name

publication date

17 November 2015

chemical structure

Daclatasvir.svg
512 × 114; 13 KB

0 references

738.385331 dalton

1 reference

language of work or name

Daclatasvir (English)

4 October 2016

chemical formula

C₄₀H₅₀N₈O₆

1 reference

language of work or name

Daclatasvir (English)

19 November 2016

canonical SMILES

CC(C)C(C(=O)N1CCCC1C2=NC=C(N2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CN=C(N5)C6CCCN6C(=O)C(C(C)C)NC(=O)OC)NC(=O)OC

1 reference

language of work or name

Daclatasvir (English)

19 November 2016

isomeric SMILES

CC(C)[C@@H](C(=O)N1CCC[C@H]1C2=NC=C(N2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CN=C(N5)[C@@H]6CCCN6C(=O)[C@H](C(C)C)NC(=O)OC)NC(=O)OC

1 reference

language of work or name

Daclatasvir (English)

19 November 2016

defined daily dose

60 milligram

route of administration

oral administration

1 reference

https://www.whocc.no/atc_ddd_index/?code=J05AX14

active ingredient in

1 reference

14 February 2018

medical condition treated

1 reference

Drug Indications Extracted from FAERS

2 October 2018

liver cirrhosis

1 reference

Drug Indications Extracted from FAERS

2 October 2018

24 July 2015

Food and Drug Administration

1 reference

Inxight: Drugs Database

2 November 2018

https://drugs.ncats.io/drug/LI2427F9CI

https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206843Orig1s000lbl.pdf

LiverTox likelihood score

LiverTox toxicity likelihood category E*

1 reference

8 April 2021

https://www.ncbi.nlm.nih.gov/books/n/livertox/Daclatasvir

11 January 2018

subject has role

xenobiotic-transporting ATPase inhibitor

1 reference

5 March 2018

essential medicine

0 references

1 reference

1 reference

CAS COVID-19 Anti-Viral Candidate Compounds

0 references

Identifiers

InChI=1S/C40H50N8O6/c1-23(2)33(45-39(51)53-5)37(49)47-19-7-9-31(47)35-41-21-29(43-35)27-15-11-25(12-16-27)26-13-17-28(18-14-26)30-22-42-36(44-30)32-10-8-20-48(32)38(50)34(24(3)4)46-40(52)54-6/h11-18,21-24,31-34H,7-10,19-20H2,1-6H3,(H,41,43)(H,42,44)(H,45,51)(H,46,52)/t31-,32-,33-,34-/m0/s1

1 reference

language of work or name

Daclatasvir (English)

19 November 2016

FKRSSPOQAMALKA-CUPIEXAXSA-N

2 references

language of work or name

Daclatasvir (English)

19 November 2016

ChEBI release 2020-09-01

CAS Registry Number

2 references

Global Substance Registration System

language of work or name

daclatasvir (English)

19 November 2016

FKRSSPOQAMALKA-CUPIEXAXSA-N

CAS Common Chemistry

9 April 2021

https://commonchemistry.cas.org/detail?cas_rn=1009119-64-5

1 reference

language of work or name

Daclatasvir (English)

19 November 2016

2 references

language of work or name

Daclatasvir (English)

19 November 2016

matched by identifier from

FKRSSPOQAMALKA-CUPIEXAXSA-N

Reaxys registry number

13077731

1 reference

language of work or name

daclatasvir (English)

4 October 2016

mapping relation type

2 references

language of work or name

DACLATASVIR (English)

19 November 2016

matched by identifier from

International Chemical Identifier

InChI=1S/C40H50N8O6/c1-23(2)33(45-39(51)53-5)37(49)47-19-7-9-31(47)35-41-21-29(43-35)27-15-11-25(12-16-27)26-13-17-28(18-14-26)30-22-42-36(44-30)32-10-8-20-48(32)38(50)34(24(3)4)46-40(52)54-6/h11-18,21-24,31-34H,7-10,19-20H2,1-6H3,(H,41,43)(H,42,44)(H,45,51)(H,46,52)/t31-,32-,33-,34-/m0/s1

1 reference

language of work or name

DACLATASVIR (English)

19 November 2016

UniChem compound ID

1 reference

DSSTox substance ID

DTXSID901026404

1 reference

matched by identifier from

FKRSSPOQAMALKA-CUPIEXAXSA-N

0 references

1 reference

language of work or name

Daclatasvir (English)

publication date

17 November 2015

0 references

Guide to Pharmacology Ligand ID

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

5 February 2021

MeSH descriptor ID

subject named as

daclatasvir

0 references

1 reference

Global Substance Registration System

language of work or name

daclatasvir (English)

19 November 2016

1 reference

matched by identifier from

FKRSSPOQAMALKA-CUPIEXAXSA-N

2 references

Global Substance Registration System

language of work or name

daclatasvir (English)

19 November 2016

matched by identifier from

FKRSSPOQAMALKA-CUPIEXAXSA-N

MedlinePlus drug identifier

0 references

1 reference

Global Substance Registration System

language of work or name

daclatasvir (English)

19 November 2016

Probes And Drugs ID

0 references

1 reference

1 reference

language of work or name

daclatasvir (English)

4 October 2016

1 reference

1 reference

6 April 2020

electronic Essential Medicines List medicine ID

0 references

0 references

Microsoft Academic ID

0 references

1 reference

26 January 2022

https://docs.openalex.org/download-snapshot/snapshot-data-format

1 reference

Global Substance Registration System

language of work or name

daclatasvir (English)

19 November 2016

WikiProjectMed ID

0 references

Sitelinks

Wikipedia(18 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q5207712&oldid=2186670104"